← All companies

ASPE

Aspen Neuroscience, Inc.

ASPE Pharmaceutical Preparations EDGAR ↗

$14.89

-0.11 -0.73%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$11.60 – $14.90

Recent SEC filings

24 most recent

Other filings

424B4 Oct 30, 2026

EFFECT Oct 29, 2026

CERT Oct 29, 2026

8-A12B Oct 29, 2026

S-1/A Oct 26, 2026

S-1/A Oct 22, 2026

S-1 Oct 9, 2026

DRS/A Jun 10, 2026

DRS/A May 12, 2026

DRS Mar 30, 2026